UnknownPhase 2NCT00993356

Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas

Studying Acromegaly

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Jiao Tong University School of Medicine
Principal Investigator
Hai-jun Wang, MD, M.D
Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University
Intervention
Preoperative lanreotide treatment(drug)
Enrollment
96 enrolled
Eligibility
18-80 years · All sexes
Timeline
20042010

Study locations (1)

Collaborators

First Affiliated Hospital, Sun Yat-Sen University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00993356 on ClinicalTrials.gov

Other trials for Acromegaly

Additional recruiting or active studies for the same condition.

See all trials for Acromegaly

← Back to all trials